Distinct gene mutation profiles among multiple and single primary lung adenocarcinoma
With the development of technologies, multiple primary lung cancer (MPLC) has been detected more frequently. Although large-scale genomics studies have made significant progress, the aberrant gene mutation in MPLC is largely unclear. In this study, 141 and 44 lesions from single and multiple primary...
Main Authors: | Yadong Wang, Guanghui Wang, Haotian Zheng, Jichang Liu, Guoyuan Ma, Gemu Huang, Qingtao Song, Jiajun Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1014997/full |
Similar Items
-
A novel NGS‐based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients
by: Xin Zhang, et al.
Published: (2023-03-01) -
SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment
by: Yong Liu, et al.
Published: (2022-10-01) -
Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
by: Jichang Liu, et al.
Published: (2022-07-01) -
Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization
by: Rachelle P. Mendoza, et al.
Published: (2024-01-01) -
The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape
by: Guanghui Wang, et al.
Published: (2022-06-01)